Kala Bio, INC. (KALA) SEC Filings — 2025
20 SEC filings for Kala Bio, INC. (KALA) in 2025.
Filings
- KALA BIO Seeks Shareholder Nod for Massive Stock Increase, Reverse Split — DEF 14A · Dec 30, 2025
- Kala Bio, INC. 8-K Filing — 8-K · Dec 29, 2025
- Kala Bio, INC. 8-K Filing — 8-K · Dec 16, 2025
- KALA BIO, Inc. Files 8-K for Material Agreement — 8-K · Dec 5, 2025
- Kala Bio Announces Material Agreements & Equity Sales — 8-K · Nov 25, 2025
- KALA BIO Halts Key Drug Development, Cuts Staff Amid Cash Crunch — 10-Q · Nov 19, 2025
- Kala Bio, INC. 8-K Filing — 8-K · Nov 12, 2025
- KALA BIO, Inc. Reports Material Agreements and Equity Sales — 8-K · Nov 10, 2025
- Kala Bio, Inc. Files 8-K on Executive Changes and Restructuring — 8-K · Oct 20, 2025
- KALA BIO, Inc. Files 8-K/A Amendment — 8-K/A · Oct 2, 2025
- KALA BIO, Inc. Reports Financial Obligation Triggering Event — 8-K · Oct 1, 2025
- KALA BIO, Inc. Files 8-K on Exit Activities — 8-K · Sep 29, 2025
- KALA BIO, Inc. Files 8-K on Shareholder Nominations — 8-K · Sep 18, 2025
- KALA BIO, Inc. Files 8-K on Executive Changes and Financials — 8-K · Sep 2, 2025
- KALA BIO Narrows Q2 Loss Amidst Continued Equity Raises — 10-Q · Aug 8, 2025
- KALA BIO, Inc. Files 8-K — 8-K · Jul 9, 2025
- Kala Bio Q1 Loss Narrows, Cash Reserves Stand at $51.25M — 10-Q · May 14, 2025
- Kala Bio Announces Board and Executive Compensation Changes — 8-K · Apr 11, 2025
- Kala Bio Files 2024 10-K, Details Securities Purchase Agreements — 10-K · Mar 31, 2025
- Kala Bio Announces Board and Executive Changes — 8-K · Feb 12, 2025